• Childhood Kidney Diseases
• /
• 제21권2호
• /
• pp.142-146
• /
• 2017

Purpose: To evaluate changes in quality of life (QoL) in patients with neurogenic bladder treated with clean intermittent catheterization (CIC), who changed from a multiple use catheter (MUC) to single use catheter (SUC). Methods: The Modified Intermittent Self-Catheterization Questionnaire (mISC-Q) was used to determine potential changes in patients' QoL as a result of switching from MUC to SUC. The mISC-Q consists of questions within four categories: ease of use, convenience, discreetness, and symptomatic benefit. Answers were graded as Strongly agree (+2), Agree (+1), Not sure (0), Disagree (-1), and Strongly disagree (-2). Overall patient QoL, as well as by sex, disease (presence of augmentation cystoplasty), and catheterization route (via urethra or urinary diversion), were analyzed. Results: Thirty-eight patients (21M:17F; mean age: $21.7{\pm}5.3y$) submitted questionnaires. For ease of use, SUC was significantly better than MUC (score: 0.364, P=0.002) in all patients. Patients with catheterization via the urethra showed significant favor for SUC in ease of use (score: 0.512, P<0.001) and convenience (score: 0.714, P=0.011), but patients with catheterization via the abdominal stoma of urinary diversion gave negative scores in all categories, though no categories were significant. Conclusion: This study suggested that changing from MUC to SUC may lead to improvements in QoL, especially regarding ease of use. This benefit was clearly found in patients with catheterization via urethra rather than abdominal stoma of urinary diversion.

• 대한한방내과학회지
• /
• 제24권2호
• /
• pp.380-386
• /
• 2003

Patients with neurogenic bladder undergo morphometric and functional changes of their bladder and urethra. As a result, voiding symptoms such as frequency, nocturia, urgency and incontinence appear. We experienced two cases of the urinary incontinence treated with Samboo-tang(Sanfu-tang). In the point of Differentiation of Syndrome, two cases were diagnosed as Deficiency Syndrome of Yang of the kidneys. After Samboo-tang(Sanfu-tang) administration, the frequency of the urinary incontinence were decreased and the accompanied symptoms also improved. So, we report two cases with a brief view of related literatures.

• Asian Spine Journal
• /
• 제12권6호
• /
• pp.981-986
• /
• 2018

Study Design: Retrospective case series. Purpose: Cauda equina syndrome (CES) is associated with etiologies such as lumbar disc herniation (LDH) and lumbar canal stenosis (LCS). CES has a prevalence of 2% among patients with LDH and exhibits variable outcomes, even with early surgery. Few studies have explored the factors influencing the prognosis in terms of bladder function. Therefore, we aimed to assess the factors contributing to bladder recovery and propose a simplified bladder recovery classification. Overview of Literature: Few reports have described the prognostic clinical factors for bladder recovery following CES. Moreover, limited data are available regarding a meaningful bladder recovery status classification useful in clinical settings. Methods: A single-center retrospective study was conducted (April 2012 to April 2015). Patients with CES secondary to LDH or LCS were included. The retrieved data were evaluated for variables such as demographics, symptom duration, neurological symptoms, bladder symptoms, and surgery duration. The variable bladder function outcome during discharge and at follow-up was recorded. All subjects were followed up for at least 2 years. A simplified bladder recovery classification was proposed. Statistical analyses were performed to study the correlation between patient variables and bladder function outcome. Results: Overall, 39 patients were included in the study. Majority of the subjects were males (79.8%) with an average age of 44.4 years. CES secondary to LDH was most commonly seen (89.7%). Perianal sensation (PAS) showed a significant correlation with neurological recovery. In the absence of PAS, bladder function did not recover. Voluntary anal contraction (VAC) was affected in all study subjects. Conclusions: Intactness of PAS was the only significant prognostic variable. Decreased or absent VAC was the most sensitive diagnostic marker of CES. We also proposed a simplified bladder recovery classification for recovery prognosis.

• Journal of Acupuncture Research
• /
• 제22권3호
• /
• pp.123-135
• /
• 2005

국내외 학술지중 배뇨장애에 대한 침치료의 연구 동향을 문헌고찰 연구, 생리적 기전 연구, 임상효과 연구로 나누어 분석한 결과 다음과 같은 결과를 얻었다. 1. 23 편의 논문 중 review study가 3편, experimental study 6편, clinical study가 14 편이었다. 다양한 Journal에 발표되고 있었는데, review study는 모두 국내 학술지에 게재 된 논문이었고, 2000년 이후로 점차 연구의 양과 관심이 증대되고 있는 추세였다. 2. 배뇨장애는 하부요로증상의 다양한 증상을 포괄하는 것으로 한의학적인 측면에서는 융폐, 소편부금(小便不禁), 빈요(頻尿), 급박요(急迫尿), 요실금(尿失禁), 림증(淋證), 야뇨(夜尿), 난요(難尿), 점적요(點滴尿), 지연요(遲延尿)등에 해당하는데, 그 대부분의 유발 원인은 신기부족(腎氣不足)등의 하초허한(下焦虛寒)에 기인하는 것으로 판단되며, 간기울결(肝氣鬱結)등의 정서적 자극과 습열(濕熱) 및 어혈(瘀血)등의 원인에 의해서도 발생할 수 있다. 3. 배뇨장애에 대한 침구치료의 생리적 기전을 대략적으로 요약한다면 침자극에 의해 부교감 신경, 대뇌의 수면-각성 체계, 뇌교 및 척추 배뇨 센타, 음부신경/골반신경을 통해 방광에 영향을 주어 방광용량의 확장 또는 배뇨 수축의 억제작용을 하는 한편, 척추 환상 회로 나 신경연접부의 지속성 흥분을 통하여 요도주의 근육에 영향을 주는 것으로 생각되어 진다. 4. 배뇨장애에 대한 침구치료의 임상효과를 요약 한다면, 융폐, 소편부통(小便不通)에 속하는 신경인성 방광(Neurogenic Bladder), 소편부금(小便不禁), 빈요(頻尿), 급박뇨(急迫尿)에 해당하는 요실금(尿失禁)(Incontinence), 림증(淋證)에 해당하는 방광염(Cycitis), 액요(液尿) (Nocturnal Enuresis), 잡요(雜尿), 점적요(點滴尿), 지연요(遲延尿)에 해당하는 전립선염/골반통 증후군 (Prostatitis/Pelvic Pain Syndrom)등의 하부 요로증상에 침구치료는 유의미한 효과가 있다. 이상으로 국내 및 해외 연구는 최근들어 더욱 활발히 연구되고 있는데, 특히 해외연구는 배뇨 장애의 침구치료의 생리적 기전 분야에서 다양 하게 시도되고 있었다. 향후 고령화 사회로 진입 하는등 사회여건상 이와같은 다양한 배뇨장애 환자의 증가는 물론 치료욕구의 증대가 예상되는 바 이러한 생리적 치료기전의 연구 및 다양한 질환에 대한 임상연구를 시도함으로써 표준적인 치료기술의 개발이 필요할 것으로 사료된다.

• Investigative and Clinical Urology
• /
• 제59권6호
• /
• pp.410-415
• /
• 2018

Purpose: Despite meticulous techniques, surgical complications continue to be problematic in kidney transplant recipients. Role of routine stenting to reduce complications is controversial. In this study, we compare incidence of early urological complications, lymphoceles, urinary tract infections (UTI) and graft function; with or without double-J stenting. Materials and Methods: All patients who underwent live related donor renal transplantation from February 2014 to February 2016 were included. Transplants prior to February 2015 were without routine stenting; subsequent transplants were with routine stenting. Patients with neurogenic bladder, previously operated bladder and delayed or low urinary output were excluded. Followup was for at least three months. Descriptive statistics was performed for all parameters. Chi square test and Fisher's Exact test were used for qualitative variables. For quantitative variables, Mann-Whitney test was used to test median difference and independent samples t-test for mean difference. The p-value ${\leq}0.05$ was considered significant. Results: We analysed 74 patients (34 stented and 40 non-stented). There was no difference in the incidence of urinary leak, anastomotic obstruction, lymphoceles or UTI (p>0.4 for all comparisons). However, mean estimated glomerular filtration rate at sixth day, 14th day, one month and two months were 76.1 vs. 61.5 (p=0.025), 72.1 vs. 56.6 (p=0.005), 79.4 vs. 63.1 (p=0.002) and 82.0 vs. 63.3 (p=0.001) in the stented versus non-stented groups. Conclusions: Placement of ureteral stent in renal transplant does not significantly affect the incidence of early urinary complications or UTI. However, graft function is significantly better in stented recipients, at least in the short term.

• International Neurourology Journal
• /
• 제22권4호
• /
• pp.287-294
• /
• 2018

Purpose: Augmentation cystoplasty (AC) is a surgical procedure used in adults and children with refractory bladder dysfunction, including a small bladder capacity and inadequate bladder compliance, and in whom conservative and medical treatment has failed. This study was aimed to determine the long-term outcomes of AC in children. Methods: A retrospective analysis was conducted of 42 patients (31 males; mean age, $14.2{\pm}6.2years$) who underwent AC for neurogenic and nonneurogenic bladder dysfunction, with a median $12.0{\pm}1.5years$ of follow-up. All patients underwent AC using the ileum with or without continent reconstruction. Pre-AC, concurrent, and post-AC procedures and complications were analyzed. Patients who underwent ureterocystoplasty, were lost to follow-up, or had less than 10 years of follow-up were excluded. The primary outcomes were the complication and continence rates, the post-AC linear rate of height and weight gain, and renal function. The Student t-test was used to evaluate between-group differences and the paired t-test was used to evaluate longitudinal changes in measured variables. Results: Renal function was stable or improved in 32 of 42 patients (76.2%), with a post-AC continence rate of 88.1%. Thirty patients (71.4%) required 72 procedures post-AC. There was no statistically significant difference in the mean percentile of height (P=0. 212) or weight (P=0.142) of patients in the pre- and post-AC periods. No cases of bladder perforation or malignancy were detected. Conclusions: We consider AC to be a safe and effective procedure that does not negatively affect future physical growth, while achieving a good rate of stable renal function. Patients need long-term follow-up to address long-term complications.

• 대한임상검사과학회지
• /
• 제52권4호
• /
• pp.417-424
• /
• 2020

이 연구는 신경인성 방광 쥐 모델에서 줄기세포에 의해 발현된 뇌유래신경영양인자가 하부요로 증상에 미치는 영향을 조사하였다. 48마리의 Sprague-Dawley 쥐를 정상군, 하부요로증상군, 하부요로증상+imMSC군 및 하부요로증상+BDNF-eMSC군으로 무작위 선정하였다. 하부요로증상모델은 골반신경절 손상에 의해 유도되었으며 방광 기능평가는 마취 하에 실시하였고, 수축성 검사 및 웨스턴 블롯 분석을 위해 방광 조직을 절제하였다. 뇌유래신경영양인자 발현 중간엽줄기세포 치료가 하부요로증상에 미치는 영향도 평가되었으며 뇌유래신경영양인자 발현 중간엽줄기세포는 방광 조직의 섬유화를 억제하였고 Caspase-3 발현을 감소시켰다. 결론적으로, 뇌유래신경영양인자 발현 중간엽줄기세포는 하부요로증상 쥐 모델에서 세포 사멸의 억제와 함께 방광의 기능 및 수축성의 회복을 가져왔다.

• 대한한방내과학회지
• /
• 제23권2호
• /
• pp.286-291
• /
• 2002

Urinary tract infection(UTI) is one of the common complications in stroke patients. As it has negative effect on the recovery of stroke, it should be cured out immediately. But antibiotics might cause some adverse reactions such as diarrhea, eruption, anorexia, nausea and vomiting. so there have been several reports about treating urinary tract infection with Traditional Korean Medication. We treated a 54-year-old male patient with cerebral hemorrhage, who had had neurogenic bladder after stroke and had been urinated by intermittent catheterization. About 10 days later, he could void by himself without catheter, but showing the symptoms of UTI; Voiding pain, hematuria and yellowish pus. The pus culture grew Staphylococcus spp., which was resistant to most of antibiotics except vancomycin and teicoplanin. Based on accompanying symptoms of intermittent dizziness, headache, insomnia, nocturnal sweating, weak pulse, red tongue and urinary problem, we differentiated him as the deficiency of Yin of the Kidney[腎陰虛] and treated with Gagamyookmijihwang-tang (Jia-Jian-Liu-Wei-De- Huang-Tang), which improved his urinary symptoms and other general conditions without any side effect. In next follow-up culture, there was no pathogen. We conclude that Traditional Korean Medicine based on differentiation is useful in the treatment of urinary tract infection.

• The Korean Journal of Pain
• /
• 제31권4호
• /
• pp.296-304
• /
• 2018

Epiduroscopy is defined as a percutaneous, minimally invasive endoscopic investigation of the epidural space. Periduroscopy is currently used mainly as a diagnostic tool to directly visualize epidural adhesions in patients with failed back surgery syndrome (FBSS), and as a therapeutic action in patients with low back pain by accurately administering drugs, releasing inflammation, washing the epidural space, and mechanically releasing the scars displayed. Considering epiduroscopy a minimally invasive technique should not lead to underestimating its potential complications. The purpose of this review is to summarize and explain the mechanisms of the side effects strictly related to the technique itself, leaving aside complications considered typical for any kind of extradural procedure (e.g. adverse reactions due to the administration of drugs or bleeding) and not fitting the usual concept of epiduroscopy for which the data on its real usefulness are still lacking. The most frequent complications and side effects of epiduroscopy can be summarized as non-persistent post-procedural low back and/or leg discomfort/pain, transient neurological symptoms (headache, hearing impairment, paresthesia), dural puncture with or without post dural puncture headache (PDPH), post-procedural visual impairment with retinal hemorrhage, encephalopathy resulting in rhabdomyolysis due to a dural tear, intradural cyst, as well as neurogenic bladder and seizures. We also report for first time, to our knowledge, a case of symptomatic pneumocephalus after epiduroscopy, and try to explain the reason for this event and the precautions to avoid this complication.

• International Neurourology Journal
• /
• 제22권4호
• /
• pp.275-286
• /
• 2018

Purpose: OnabotulinumtoxinA (BoNT-A) is a promising therapy for treating neurogenic detrusor overactivity (NDO) in individuals with spinal cord injury (SCI). This systematic review and meta-analysis aimed to carry out an in-depth review and to make an objective estimation of the efficacy and safety of BoNT-A on NDO after SCI. Methods: The PubMed, Embase, and Cochrane databases were searched for all relevant articles published from 2001 to 2016 that referred to NDO, SCI, and BoNT-A or botulinum toxin A. All data were recorded in an Excel spreadsheet by 2 individual reviewers. Review Manager version 5.3 was used to carry out the meta-analysis. Results: This analysis included 17 studies involving 1,455 patients. Compared with placebo and baseline, BoNT-A was effective in increasing maximum cystometric capacity, volume at first involuntary detrusor contraction, cystometric bladder capacity (all P<0.00001), compliance (P=0.001), and the number of patients with complete dryness (P=0.0003), and decreasing detrusor pressure, the number of patients with no involuntary detrusor contractions, the maximum flow rate, the incidence of detrusor overactivity (all P<0.00001), and the number of urinary incontinence episodes (P=0.001). There were no statistically significant differences between doses of 200 U and 300 U or between injections into the detrusor and submucosa. There were no life-threatening adverse events. Conclusions: BoNT-A is effective and safe in treating NDO after SCI. There were no statistically significant differences between doses of 200 U and 300 U or between injecting into the detrusor and submucosa. However, more high-quality randomized controlled trials are still needed.